Sawai Pharmaceutical's First Quarter Profit Doubles
This article was originally published in PharmAsia News
Executive Summary
Japan's largest generic drug maker Sawai Pharmaceutical announced Aug. 7 positive results for the quarter. Company profit doubled to ¥1.85 billion compared to the same period last year. Sawai cited the further expanding generic drug market in Japan stimulated by the government policy to constrain medical cost growth, and a May market launch for new products instead of July in last year's case. The company's share price jumped due to the news. (Click here for more - Japanese language